Últimas noticias sobre Alphatec Holdings (NASDAQ:ATEC) Bolsa

Alphatec Holdings

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Alphatec Holdings Inc

Atec Inc

HC Wainwright &amp; Co. analyst Sean Lee reiterates Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Buy and maintains $20 price target.

News

Price Target

Reiteration

Analyst Ratings

ATEC

HC Wainwright & Co. Reiterates Buy on Alphatec Holdings, Maintains $20 Price Target

Offerings

Reported Earlier, Alphatec Holdings Announced The Pricing Of Its Offering Of $350M Aggregate Principal Amount Of 0.75% Convertible Senior Notes Due 2030 In A Private Offering

WIIM

Alphatec shares are trading lower after the company announced a proposed $300 million convertible senior note offering.

Alphatec Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced its intention to offer, subject to market and other conditions, $300,000,000 aggregate principal amount of convertible senior notes due 2030 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). ATEC also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $50,000,000 principal amount of notes.

ATEC Announces Proposed $300M Convertible Senior Notes Offering Due 2030

Alphatec shares are trading higher after Piper Sandler raised its price target on the stock from $12 to $13.

Piper Sandler analyst Matt O'Brien maintains Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Overweight and raises the price target from $12 to $13.

Piper Sandler Maintains Overweight on Alphatec Holdings, Raises Price Target to $13

Needham analyst David Saxon reiterates Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Buy and maintains $16 price target.

Needham Reiterates Buy on Alphatec Holdings, Maintains $16 Price Target

Alphatec Holdings shares are trading lower following a Q4 EPS miss.

Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) affirms FY2025 sales outlook from $732.00 million to $732.00 million vs $731.39 million estimate.

Guidance

Alphatec Holdings Affirms FY2025 Sales Guidance of $732.00M vs $731.39M Est

Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.19) by 21.05 percent. This is a 37.84 percent increase over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $176.79 million which beat the analyst consensus estimate of $172.49 million by 2.50 percent. This is a 28.14 percent increase over sales of $137.97 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Alphatec Holdings Q4 EPS $(0.23) Misses $(0.19) Estimate, Sales $176.79M Beat $172.49M Estimate

AAOI

ABEV

ACAD

ACMR

ADTN

ALEC

AMBA

AMBC

AMSF

ARDT

ARHS

ARIS

ARKO

ASTE

AVDX

AVNS

BATRA

BATRK

BBSI

BLMN

BXSL

BYND

CAPL

CDNA

CERT

CLDT

CLPT

COCO

COMM

CORT

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRGY

CSAN

CTRI

DHIL

DMRC

DOLE

DORM

EBAY

ECPG

EHTH

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FTAI

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

GRBK

HCAT

HNST

IBTA

IMCR

Earnings Scheduled For February 26, 2025

Barclays analyst Matt Miksic maintains Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Overweight and raises the price target from $20 to $21.

Barclays Maintains Overweight on Alphatec Holdings, Raises Price Target to $21

Alphatec shares are trading higher after the company announced preliminary FY24 and FY25 revenue results above estimates. Also, Needham raised its price target on the stock from $13 to $16.

Needham analyst David Saxon maintains Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Buy and raises the price target from $13 to $16.

Needham Maintains Buy on Alphatec Holdings, Raises Price Target to $16

Alphatec Holdings Sees FY25 Revenue $732M Vs $729.465M Est.

Alphatec Holdings Sees Prelim. FY24 Revenue $610.3M-$611.8M Vs $605.109M Est.

Alphatec Holdings Sees Prelim. Q4 Revenue $175.5M-$177.0M Vs $170.317M Est.

Barclays analyst Matt Miksic maintains Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Overweight and raises the price target from $19 to $20.

Barclays Maintains Overweight on Alphatec Holdings, Raises Price Target to $20

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping around 500 points on Thursday.
The Dow traded down 0.62% to 41,880.03 while the NASDAQ fell 2.69% to 18,107.65. The S&amp;P 500 also fell, dropping, 1.64% to 5,718.50.
Check This Out: <a href="https://www.benzinga.com/news/24/10/41653495/top-2-real-estate-stocks-you-may-want-to-dump-this-quarter">Top 2 Real Estate Stocks You May Want To Dump This Quarter</a>
Leading and Lagging Sectors Utilities shares rose by 1.6% on Thursday.
In trading on Thursday, information technology shares fell by 3.4%.
Top Headline
Shares of Uber Technologies, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) dipped more than 10% on Thursday after the company reported quarterly results.
The company posted fiscal third-quarter 2024 revenue growth of 20% year-on-year to $11.188 billion, beating the analyst consensus of $10.97 billion. Uber reported GAAP EPS of 46 cents and adjusted EPS of 46 cents, which beat the analyst consensus of 41 cents.
Trips grew 17% year-over-year to 2.9 billion, or 31 million per day. Uber&#8217;s Monthly Active Platform Consumers reached 161 million, up 13% year-over-year.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Root, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) shares shot up 77% to $72.03 after the company reported better-than-expected third-quarter financial results.</li>
<li>Shares of Alphatec Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) got a boost, surging 39% to $7.82 after the company reported better-than-expected third-quarter revenue results and raised its FY24 revenue guidance.</li>
<li>Lemonade, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) shares were also up, gaining 27% to $23.89 after the company reported third-quarter earnings and sales above estimates and raised its FY24 guidance.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Matinas BioPharma Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTNB#NYSE">MTNB</a>) shares dropped 65% to $0.6700 after the company announced the termination of negotiations under the previously disclosed non-binding term sheet regarding global rights to MAT2203. Matinas has implemented an 80% reduction in its workforce.</li>
<li>Shares of Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) were down 24% to $5.01 after reporting a wider-than-expected quarterly loss.</li>
<li>COMPASS Pathways plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) was down, falling 23% to $4.7750 after the company announced it pushed its topline data readout from its COMP005 Phase 3 trial to Q2 2025 and its COMP006 data will be announced after the 26-week time point.</li>
</ul>
Commodities In commodity news, oil traded up 1% to $69.30 while gold traded down 1.8% at $2,751.50.
Silver traded down 3.7% to $32.820 on Thursday, while copper fell 0.1% to $4.3475.
Euro zone
European shares were lower today. The eurozone's STOXX 600 dipped 1.20%, Germany's DAX fell 0.93% and France's CAC 40 slipped 1.05%. Spain's IBEX 35 Index fell 0.36%, while London's FTSE 100 fell 0.61%.
Asia Pacific Markets
Asian markets closed mostly lower on Thursday, with Japan's Nikkei 225 falling 0.50%, Hong Kong's Hang Seng Index falling 0.31%, China's Shanghai Composite Index gaining 0.42% and India's BSE Sensex falling 0.69%.
Economics
<ul>
<li>U.S. initial jobless claims declined by 12,000 from the previous week to 216,000 in the week ending Oct. 26.</li>
<li>U.S. personal income increased by 0.3% from the prior month to $24.948 trillion in September, while personal spending increased by 0.5% to an annualized rate of $20.024 trillion.</li>
<li>The personal consumption expenditure price index rose 0.2% month-over-month in September following a 0.1% increase in August.</li>
<li>U.S. natural-gas supplies rose 78 billion cubic feet to 8.863 trillion cubic feet in the week ended Oct. 25.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41652163/jim-cramer-this-financial-stock-is-one-of-the-most-consistent-great-companies">Jim Cramer: This Financial Stock Is &#8216;One Of The Most Consistent, Great Companies&#8217;</a></li>
</ul>

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

CMPS

LMND

MTNB

ROOT

UBER

Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results

Press Releases

ATEC Reports Third Quarter 2024 Financial Results And Raises Full-Year Guidance

ATEC to Participate in Upcoming Conferences

ATEC to Present at the 2025 J.P. Morgan Healthcare Conference

Paragon 28 Appoints Dave Demski to Board of Directors

ATEC Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook

ATEC Reports Fourth Quarter and Full Year 2024 Financial Results

ATEC Announces Proposed Convertible Senior Notes Offering

ATEC Prices Upsized $350.0 Million Convertible Senior Notes Offering

ATEC to Report First Quarter 2025 Financial Results on May 1, 2025

Artivion

AtriCure

Axogen

Butterfly Network, Inc. Class A Common Stock

Butterfly Network

CeriBell

Conmed

Enovis

Paragon 28

Integra LifeSciences Holdings Corporation - Common Stock

Integra Lifesciences

Inspire Medical Systems, Inc. Common Stock

Inspire Medical Systems

iRadimed

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies

Integer Holdings Corporation Common Stock

Integer Holdings

Kestra Medical Technologies, Ltd. - Common Stock

Kestra Medical Techs

LeMaitre Vascular

NovoCure

Envista Holdings Corporation Common Stock

Envista Holdings

Orthofix Medical

Omnicell

Pulse Biosciences

PROCEPT BioRobotics Corporation - Common Stock

PROCEPT BioRobotics

QuidelOrtho

SI-BONE

TransMedics Group

Tandem Diabetes Care, Inc. - Common Stock

Tandem Diabetes Care

HC Wainwright & Co.

Piper Sandler

Needham

Barclays

Lake Street

Comments

Alphatec Holdings

Noticias

Últimas noticias sobre Alphatec Holdings (NASDAQ:ATEC) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL